Cargando…

Dapagliflozin-affected endothelial dysfunction and altered gut microbiota in mice with heart failure

AIM: To investigate the potential microbiome profile of a mouse model with heart failure (HF) during dapagliflozin treatment. METHOD: An HF model was constructed in 8-week-old male mice, and cardiac tissues were analyzed using histological staining. Hemodynamic indexes were measured, and fecal sampl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bao, Nandi, Liu, Xiaoli, Zhong, Xiaoling, Jia, Shuangshuang, Hua, Ning, Zhang, Li, Mo, Guoxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2023
Materias:	Molecular Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386824/ https://www.ncbi.nlm.nih.gov/pubmed/37520255 http://dx.doi.org/10.7717/peerj.15589

Ejemplares similares

SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice
por: Lee, Dustin M., et al.
Publicado: (2018)

Prediction Correction Topic Evolution Research for Metabolic Pathways of the Gut Microbiota
por: Ning, Li, et al.
Publicado: (2020)

Effects of the Lipid Metabolites and the Gut Microbiota in ApoE(−/−) Mice on Atherosclerosis Co-Depression From the Microbiota-Gut-Brain Axis
por: Hu, Ke, et al.
Publicado: (2022)

Gut Microbiota and Endothelial Dysfunction Markers in Obese Mexican Children and Adolescents
por: Nirmalkar, Khemlal, et al.
Publicado: (2018)

Effects of Dapagliflozin on Endothelial Dysfunction in Type 2 Diabetes With Established Ischemic Heart Disease (EDIFIED)
por: Zainordin, Nur Aisyah, et al.
Publicado: (2019)

Integrative Analysis of Long Non-coding RNAs, Messenger RNAs, and MicroRNAs Indicates the Neurodevelopmental Dysfunction in the Hippocampus of Gut Microbiota-Dysbiosis Mice
por: Liu, Lanxiang, et al.
Publicado: (2022)

Alterations of the Gut Microbiota in Patients With Severe Chronic Heart Failure
por: Sun, Weiju, et al.
Publicado: (2022)

Metabolic Alterations in Cardiopulmonary Vascular Dysfunction
por: Smolders, Valérie Françoise, et al.
Publicado: (2019)

Dapagliflozin effect on endothelial dysfunction in diabetic patients with atherosclerotic disease: a randomized active-controlled trial
por: Sposito, Andrei C., et al.
Publicado: (2021)

Polyethylene Glycol Loxenatide Injection (GLP-1) Protects Vascular Endothelial Cell Function in Middle-Aged and Elderly Patients With Type 2 Diabetes by Regulating Gut Microbiota
por: Chen, Fengwu, et al.
Publicado: (2022)

Dapagliflozin Attenuates Heart Failure With Preserved Ejection Fraction Remodeling and Dysfunction by Elevating β-Hydroxybutyrate–activated Citrate Synthase
por: Zhang, Xinxin, et al.
Publicado: (2023)

Current Status of Dapagliflozin in Congestive Heart Failure
por: Palandurkar, Gopal, et al.
Publicado: (2022)

Gut microbiota-derived propionate reduces cancer cell proliferation in the liver
por: Bindels, L B, et al.
Publicado: (2012)

Do an Altered Gut Microbiota and an Associated Leaky Gut Affect COVID-19 Severity?
por: Kim, Heenam Stanley
Publicado: (2021)

Butyrate attenuated fat gain through gut microbiota modulation in db/db mice following dapagliflozin treatment
por: Oh, Tae Jung, et al.
Publicado: (2019)

Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure
por: Kamo, Takehiro, et al.
Publicado: (2017)

Inhibition of MAOB Ameliorated High-Fat-Diet-Induced Atherosclerosis by Inhibiting Endothelial Dysfunction and Modulating Gut Microbiota
por: Tian, Zhen, et al.
Publicado: (2023)

Dapagliflozin protects neural and vascular dysfunction of the retina in diabetes
por: Luo, Qianyi, et al.
Publicado: (2022)

The Contribution of Gut Microbiota and Endothelial Dysfunction in the Development of Arterial Hypertension in Animal Models and in Humans
por: Maiuolo, Jessica, et al.
Publicado: (2022)

Genomic reconstruction of short-chain fatty acid production by the human gut microbiota
por: Frolova, Maria S., et al.
Publicado: (2022)

Understanding the Holobiont: Crosstalk Between Gut Microbiota and Mitochondria During Long Exercise in Horse
por: Mach, Núria, et al.
Publicado: (2021)

Low fibre intake is associated with gut microbiota alterations in chronic heart failure
por: Mayerhofer, Cristiane C.K., et al.
Publicado: (2020)

Alteration of the gut microbiota and metabolite phenylacetylglutamine in patients with severe chronic heart failure
por: Zhang, Zhendong, et al.
Publicado: (2023)

Combined treatment with sacubitril/valsartan plus dapagliflozin in patients affected by heart failure with reduced ejection fraction
por: Jiang, Juan, et al.
Publicado: (2023)

High-fat diet-induced gut microbiota alteration promotes lipogenesis by butyric acid/miR-204/ACSS2 axis in chickens
por: Chen, Can, et al.
Publicado: (2023)

Impact of HIV and Type 2 diabetes on Gut Microbiota Diversity, Tryptophan Catabolism and Endothelial Dysfunction
por: Hoel, Hedda, et al.
Publicado: (2018)

Gut microbiota-derived metabolite trimethylamine-N-oxide and stroke outcome: a systematic review
por: Zhang, Peng, et al.
Publicado: (2023)

Dynamic Alterations of the Gut Microbial Pyrimidine and Purine Metabolism in the Development of Liver Cirrhosis
por: Xiong, Yinghui, et al.
Publicado: (2022)

Gut microbiota diversity and specific composition during immunotherapy in responders with non-small cell lung cancer
por: Shoji, Fumihiro, et al.
Publicado: (2022)

Alterations in Gut Microbiota Are Correlated With Serum Metabolites in Patients With Insomnia Disorder
por: Zhou, Jing, et al.
Publicado: (2022)

The Role of Dapagliflozin in the Management of Heart Failure: An Update on the Emerging Evidence
por: Gupta, Manasvi, et al.
Publicado: (2021)

Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics
por: Yeoh, Su Ern, et al.
Publicado: (2023)

NU9056, a KAT 5 Inhibitor, Treatment Alleviates Brain Dysfunction by Inhibiting NLRP3 Inflammasome Activation, Affecting Gut Microbiota, and Derived Metabolites in LPS-Treated Mice
por: Chen, Lu, et al.
Publicado: (2021)

Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)
por: Serenelli, Matteo, et al.
Publicado: (2020)

Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents
por: Wang, Xifan, et al.
Publicado: (2020)

Current understanding of gut microbiota alterations and related therapeutic intervention strategies in heart failure
por: Chen, Xi, et al.
Publicado: (2019)

The gut microbiota is important for the maintenance of blood–cerebrospinal fluid barrier integrity
por: Knox, Emily G., et al.
Publicado: (2022)

Glycan-related genes in human gut microbiota exhibit differential distribution and diversity in carbohydrate degradation and glycan synthesis
por: Takihara, Hayato, et al.
Publicado: (2023)

Gut microbiota in sarcopenia and heart failure
por: Liu, Chia-Feng, et al.
Publicado: (2022)

The protective effects and underlying mechanisms of dapagliflozin on diabetes-induced testicular dysfunction
por: Luo, Zhi-Chao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qs2nualpu42ccebbahpctcmi55